SPX (SPXC) Q3 2025 Earnings Call Transcript

SPX reported Q3 adjusted EPS of $1.84, up 32% year over year, on revenue of $616 million, up 23%, and raised full-year EPS guidance to $6.65-$6.80 from $6.35-$6.65. Adjusted EBITDA is now expected to exceed $500 million at the midpoint, while liquidity rose by more than $1 billion to over $1.6 billion after a $575 million equity offering and a $500 million revolver increase with no 2025 EPS dilution. Both HVAC and Detection & Measurement posted strong growth, backlog remained near record levels, and management reiterated positive momentum in Olympus Max, TAMCO, Ingénia, and the M&A pipeline.

Analysis

The market is underappreciating how much of this step-up is self-reinforcing rather than cyclical. SPXC is turning backlog into higher-margin conversion while simultaneously expanding capacity in the exact product lines tied to secular demand pools (data centers, power, hydronics), which means incremental revenue should carry better operating leverage than the street likely models into 2026. The combination of stronger liquidity and low balance-sheet leverage also lowers execution risk on larger acquisitions, which matters because the company’s historical playbook has been to buy under-optimized assets and layer on distribution/engineering synergies.

The more interesting second-order effect is competitive. Olympus Max looks less like a one-off product launch and more like a wedge into a design-in market where switching costs rise once a spec is written around the platform. If management is right that water-cooled architectures keep gaining share, the addressable market expands without SPXC needing to win share from incumbents in the traditional channel only; it can also monetize the systems transition itself. That creates a multi-year option on 2027-2028 growth, not just a 2026 earnings beat.

The bear case is less about near-term demand and more about normalization risk: some project revenue was pulled forward, and the D&M mix is benefiting from unusually strong execution plus integration uplift. If hyperscaler timing slips or if 2026 project conversion is less favorable, the growth rate can decelerate sharply even if absolute dollars remain healthy. The key tell over the next 1-2 quarters will be whether backlog converts cleanly while TAMCO and the new U.S. Ingénia capacity ramp without margin leakage; if that happens, the market may need to re-rate this from a good industrial to a compounded platform story.

Key Decisions for Investors

• Long SPXC on a 3-6 month horizon: favor pullbacks over strength; the setup supports continued estimate revisions, with upside if Q4 cash flow confirms capital deployment optionality.
• Buy SPXC Jan-2027 call spreads (e.g., 90/120) to express the 2027-2028 data-center and capacity-expansion option with defined downside; thesis breaks if Olympus Max fails to win design-ins.
• Pair trade: long SPXC / short a slower-growth HVAC peer with weaker backlog and less exposure to data-center cooling, to isolate secular product-cycle share gains from broad industrial beta.
• Use any post-earnings drift lower to add, but keep a tight stop if D&M backlog starts to soften sequentially for two quarters, because the forward growth narrative depends on project conversion staying ahead of schedule.
• If the stock rerates sharply on M&A speculation, trim into strength: the main risk is paying up for the story before the next inorganic catalyst, since the current setup already prices in a lot of execution.